Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Clearance Models: Noncompartmental Models

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Learning to Diagnose Privately: DP-Powered LLMs for Radiology Report Classification.

IEEE access : practical innovations, open solutions·2026

Same author

Evolving language of pediatric anxiety in electronic health records.

JAMIA open·2026

Same author

Air Pollution and Cardiovascular Risks in Testicular Cancer Survivors: An Exploratory Case-Crossover Study.

Journal of adolescent and young adult oncology·2025

Same author

Evaluating algorithmic bias on biomarker classification of breast cancer pathology reports.

JAMIA open·2025

Same author

Machine learning and deep learning tools for the automated capture of cancer surveillance data.

Journal of the National Cancer Institute. Monographs·2024

Same author

Comparing maternal factors associated with postpartum depression between primiparous adolescents and adults: A large retrospective cohort study.

Birth (Berkeley, Calif.)·2023

Same journal

Effect of a Multidimensional Digital Health Intervention on Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial.

JCO clinical cancer informatics·2026

Same journal

Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?

JCO clinical cancer informatics·2026

Same journal

Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers.

JCO clinical cancer informatics·2026

Same journal

Foundation Model-Driven Regions of Interest Classification and Renaming in Cancer Radiotherapy: A Customizable, Retraining-Free Workflow Across Institutions.

JCO clinical cancer informatics·2026

Same journal

Announcing a New Article Type in <i>JCO Clinical Cancer Informatics</i>: The Resource Report.

JCO clinical cancer informatics·2026

Same journal

A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG Studies.

JCO clinical cancer informatics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Mitigating Algorithmic Bias in Cancer Site Classification Models.

Abhishek Shivanna¹, Adam Spannaus¹, Jordan Tschida¹

¹Advanced Computing for Health Sciences, Oak Ridge National Laboratory, Oak Ridge, TN.

JCO Clinical Cancer Informatics

|March 11, 2026

Summary

This summary is machine-generated.

This study found that artificial intelligence models for cancer diagnostics do not significantly encode racial bias in their predictions. Removing race-correlated data dimensions did not impact diagnostic accuracy, confirming model fairness.

Related Experiment Videos

Last Updated: Jun 26, 2026

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Area of Science:

Artificial Intelligence
Oncology
Medical Informatics

Background:

Artificial intelligence (AI) enhances cancer diagnostics, but may perpetuate demographic biases.
Deep learning models require rigorous bias evaluation for equitable healthcare.

Purpose of the Study:

Quantify race information encoded in AI cancer diagnostic models.
Assess performance changes after removing race-correlated data dimensions.

Main Methods:

Trained a deep learning model on 3.5 million cancer pathology reports.
Used hierarchical self-attention networks for document embeddings.
Performed post-training pruning of race-correlated dimensions to assess impact on accuracy and fairness.

Main Results:

Minimal overlap found between cancer site and race prediction features.
Removing race-correlated dimensions negligibly affected diagnostic accuracy (0.07% loss).
No significant demographic bias influenced clinical predictions.

Conclusions:

AI embeddings from SEER data are effective for cancer site classification without significant bias.
Post-training pruning serves as a viable audit for AI model fairness.